TP53 and cancer: PRIMA-1 has also been combined with SHetA2, a small molecule heteroarotinoid that induces G1 cycle arrest and apoptosis in cancer [150] and may also activate p53 by interfering with p53 repression by mortalin, a protein that can bind and inactivate p53 in the cytoplasm [151,176].